Skip to main content
Top
Published in: Cancer Immunology, Immunotherapy 12/2008

01-12-2008 | Original Article

Kinetics of anti-carcinoembryonic antigen antibody internalization: effects of affinity, bivalency, and stability

Authors: Michael M. Schmidt, Greg M. Thurber, K. Dane Wittrup

Published in: Cancer Immunology, Immunotherapy | Issue 12/2008

Login to get access

Abstract

Theoretical analyses suggest that the cellular internalization and catabolism of bound antibodies contribute significantly to poor penetration into tumors. Here we quantitatively assess the internalization of antibodies and antibody fragments against the commonly targeted antigen carcinoembryonic antigen (CEA). Although CEA is often referred to as a non-internalizing or shed antigen, anti-CEA antibodies and antibody fragments are shown to be slowly endocytosed by LS174T cells with a half-time of 10–16 h, a time scale consistent with the metabolic turnover rate of CEA in the absence of antibody. Anti-CEA single chain variable fragments (scFvs) with significant differences in affinity, stability against protease digestion, and valency exhibit similar uptake rates of bound antibody. In contrast, one anti-CEA IgG exhibits unique binding and trafficking properties with twice as many molecules bound per cell at saturation and significantly faster cellular internalization after binding. The internalization rates measured herein can be used in simple computational models to predict the microdistribution of these antibodies in tumor spheroids.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ackerman M, Chalouni C, Raman V, Schmidt M, Ritter G, Mellman I, Wittrup KD (2008) A33 antigen displays persistent surface expression. Cancer Immunol Immunother (in press) Ackerman M, Chalouni C, Raman V, Schmidt M, Ritter G, Mellman I, Wittrup KD (2008) A33 antigen displays persistent surface expression. Cancer Immunol Immunother (in press)
2.
go back to reference Adams GP et al (2001) High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules. Cancer Res 61:4750–4755PubMed Adams GP et al (2001) High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules. Cancer Res 61:4750–4755PubMed
3.
4.
go back to reference Austin CD et al (2004) Endocytosis and sorting of ErbB2 and the site of action of cancer therapeutics trastuzumab and geldanamycin. Mol Biol Cell 15:5268–5282PubMedCrossRef Austin CD et al (2004) Endocytosis and sorting of ErbB2 and the site of action of cancer therapeutics trastuzumab and geldanamycin. Mol Biol Cell 15:5268–5282PubMedCrossRef
5.
go back to reference Baxter LT, Jain RK (1991) Transport of fluid and macromolecules in tumors. III. Role of binding and metabolism. Microvasc Res 41:5–23PubMedCrossRef Baxter LT, Jain RK (1991) Transport of fluid and macromolecules in tumors. III. Role of binding and metabolism. Microvasc Res 41:5–23PubMedCrossRef
6.
go back to reference Beckman RA, Weiner LM, Davis HM (2007) Antibody constructs in cancer therapy: protein engineering strategies to improve exposure in solid tumors. Cancer 109:170–179PubMedCrossRef Beckman RA, Weiner LM, Davis HM (2007) Antibody constructs in cancer therapy: protein engineering strategies to improve exposure in solid tumors. Cancer 109:170–179PubMedCrossRef
7.
go back to reference Behr TM et al (2000) Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies. Eur J Nucl Med 27:753–765PubMedCrossRef Behr TM et al (2000) Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies. Eur J Nucl Med 27:753–765PubMedCrossRef
8.
go back to reference Bryan JN et al (2005) Comparative uptakes and biodistributions of internalizing versus noninternalizing copper-64 radioimmunoconjugates in cell and animal models of colon cancer. Nucl Med Biol 32:851–858PubMedCrossRef Bryan JN et al (2005) Comparative uptakes and biodistributions of internalizing versus noninternalizing copper-64 radioimmunoconjugates in cell and animal models of colon cancer. Nucl Med Biol 32:851–858PubMedCrossRef
9.
go back to reference Cai W et al (2007) PET imaging of colorectal cancer in xenograft-bearing mice by use of an 18F-labeled T84.66 anti-carcinoembryonic antigen diabody. J Nucl Med 48:304–310PubMedCrossRef Cai W et al (2007) PET imaging of colorectal cancer in xenograft-bearing mice by use of an 18F-labeled T84.66 anti-carcinoembryonic antigen diabody. J Nucl Med 48:304–310PubMedCrossRef
10.
go back to reference Casalini P et al (1997) Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization. J Nucl Med 38:1378–1381PubMed Casalini P et al (1997) Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization. J Nucl Med 38:1378–1381PubMed
11.
go back to reference Dooley H et al (1998) Stabilization of antibody fragments in adverse environments. Biotechnol Appl Biochem 28(Pt 1):77–83PubMed Dooley H et al (1998) Stabilization of antibody fragments in adverse environments. Biotechnol Appl Biochem 28(Pt 1):77–83PubMed
12.
go back to reference Fallon EM, Lauffenburger DA (2000) Computational model for effects of ligand/receptor binding properties on interleukin-2 trafficking dynamics and T cell proliferation response. Biotechnol Prog 16:905–916PubMedCrossRef Fallon EM, Lauffenburger DA (2000) Computational model for effects of ligand/receptor binding properties on interleukin-2 trafficking dynamics and T cell proliferation response. Biotechnol Prog 16:905–916PubMedCrossRef
13.
go back to reference Fan Z et al (1994) Antibody-induced epidermal growth factor receptor dimerization mediates inhibition of autocrine proliferation of A431 squamous carcinoma cells. J Biol Chem 269:27595–27602PubMed Fan Z et al (1994) Antibody-induced epidermal growth factor receptor dimerization mediates inhibition of autocrine proliferation of A431 squamous carcinoma cells. J Biol Chem 269:27595–27602PubMed
14.
go back to reference Ford CH et al (1996) Novel flow cytometric analysis of the progress and route of internalization of a monoclonal anti-carcinoembryonic antigen (CEA) antibody. Cytometry 23:228–240PubMedCrossRef Ford CH et al (1996) Novel flow cytometric analysis of the progress and route of internalization of a monoclonal anti-carcinoembryonic antigen (CEA) antibody. Cytometry 23:228–240PubMedCrossRef
15.
go back to reference Friedman LM et al (2005) Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: implications for cancer immunotherapy. Proc Natl Acad Sci USA 102:1915–1920PubMedCrossRef Friedman LM et al (2005) Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: implications for cancer immunotherapy. Proc Natl Acad Sci USA 102:1915–1920PubMedCrossRef
16.
go back to reference Fujimori K et al (1990) A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier. J Nucl Med 31:1191–1198PubMed Fujimori K et al (1990) A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier. J Nucl Med 31:1191–1198PubMed
17.
go back to reference Graff CP et al (2004) Directed evolution of an anti-carcinoembryonic antigen scFv with a 4-day monovalent dissociation half-time at 37 °C. Protein Eng Des Sel 17:293–304PubMedCrossRef Graff CP et al (2004) Directed evolution of an anti-carcinoembryonic antigen scFv with a 4-day monovalent dissociation half-time at 37 °C. Protein Eng Des Sel 17:293–304PubMedCrossRef
18.
go back to reference Graff CP, Wittrup KD (2003) Theoretical analysis of antibody targeting of tumor spheroids: importance of dosage for penetration, and affinity for retention. Cancer Res 63:1288–1296PubMed Graff CP, Wittrup KD (2003) Theoretical analysis of antibody targeting of tumor spheroids: importance of dosage for penetration, and affinity for retention. Cancer Res 63:1288–1296PubMed
19.
go back to reference Hammarstrom S (1999) The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol 9:67–81PubMedCrossRef Hammarstrom S (1999) The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol 9:67–81PubMedCrossRef
20.
go back to reference Hedin A, Hammarstrom S, Larsson A (1982) Specificities and binding properties of eight monoclonal antibodies against carcinoembryonic antigen. Mol Immunol 19:1641–1648PubMedCrossRef Hedin A, Hammarstrom S, Larsson A (1982) Specificities and binding properties of eight monoclonal antibodies against carcinoembryonic antigen. Mol Immunol 19:1641–1648PubMedCrossRef
21.
go back to reference Jain RK (2001) Delivery of molecular and cellular medicine to solid tumors. Adv Drug Deliv Rev 46:149–168PubMedCrossRef Jain RK (2001) Delivery of molecular and cellular medicine to solid tumors. Adv Drug Deliv Rev 46:149–168PubMedCrossRef
22.
go back to reference Kraeber-Bodere F et al (2006) Targeting, toxicity, and efficacy of 2-Step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial. J Nucl Med 47:247–255PubMed Kraeber-Bodere F et al (2006) Targeting, toxicity, and efficacy of 2-Step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial. J Nucl Med 47:247–255PubMed
23.
go back to reference Kyriakos RJ et al (1992) The fate of antibodies bound to the surface of tumor cells in vitro. Cancer Res 52:835–842PubMed Kyriakos RJ et al (1992) The fate of antibodies bound to the surface of tumor cells in vitro. Cancer Res 52:835–842PubMed
24.
go back to reference Lee YC et al (2002) Reversible dimer formation and stability of the anti-tumour single-chain Fv antibody MFE-23 by neutron scattering, analytical ultracentrifugation, and NMR and FT-IR spectroscopy. J Mol Biol 320:107–127PubMedCrossRef Lee YC et al (2002) Reversible dimer formation and stability of the anti-tumour single-chain Fv antibody MFE-23 by neutron scattering, analytical ultracentrifugation, and NMR and FT-IR spectroscopy. J Mol Biol 320:107–127PubMedCrossRef
25.
go back to reference Liu G et al (2005) Further investigations of morpholino pretargeting in mice–establishing quantitative relations in tumor. Eur J Nucl Med Mol Imaging 32:1115–1123PubMedCrossRef Liu G et al (2005) Further investigations of morpholino pretargeting in mice–establishing quantitative relations in tumor. Eur J Nucl Med Mol Imaging 32:1115–1123PubMedCrossRef
26.
go back to reference Lund KA et al (1990) Quantitative analysis of the endocytic system involved in hormone-induced receptor internalization. J Biol Chem 265:15713–15723PubMed Lund KA et al (1990) Quantitative analysis of the endocytic system involved in hormone-induced receptor internalization. J Biol Chem 265:15713–15723PubMed
27.
go back to reference Mattes MJ (2005) Binding parameters of antibodies: pseudo-affinity and other misconceptions. Cancer Immunol Immunother 54:513–516PubMedCrossRef Mattes MJ (2005) Binding parameters of antibodies: pseudo-affinity and other misconceptions. Cancer Immunol Immunother 54:513–516PubMedCrossRef
28.
go back to reference Mayor S, Rothberg KG, Maxfield FR (1994) Sequestration of GPI-anchored proteins in caveolae triggered by cross-linking. Science 264:1948–1951PubMedCrossRef Mayor S, Rothberg KG, Maxfield FR (1994) Sequestration of GPI-anchored proteins in caveolae triggered by cross-linking. Science 264:1948–1951PubMedCrossRef
29.
go back to reference Paxton RJ et al (1987) Sequence analysis of carcinoembryonic antigen: identification of glycosylation sites and homology with the immunoglobulin supergene family. Proc Natl Acad Sci USA 84:920–924PubMedCrossRef Paxton RJ et al (1987) Sequence analysis of carcinoembryonic antigen: identification of glycosylation sites and homology with the immunoglobulin supergene family. Proc Natl Acad Sci USA 84:920–924PubMedCrossRef
30.
go back to reference Rao BM, Lauffenburger DA, Wittrup KD (2005) Integrating cell-level kinetic modeling into the design of engineered protein therapeutics. Nat Biotechnol 23:191–194PubMedCrossRef Rao BM, Lauffenburger DA, Wittrup KD (2005) Integrating cell-level kinetic modeling into the design of engineered protein therapeutics. Nat Biotechnol 23:191–194PubMedCrossRef
31.
go back to reference Reiter Y et al (1996) Engineering antibody Fv fragments for cancer detection and therapy: disulfide-stabilized Fv fragments. Nat Biotechnol 14:1239–1245PubMedCrossRef Reiter Y et al (1996) Engineering antibody Fv fragments for cancer detection and therapy: disulfide-stabilized Fv fragments. Nat Biotechnol 14:1239–1245PubMedCrossRef
32.
go back to reference Sharma SK et al (2005) Sustained tumor regression of human colorectal cancer xenografts using a multifunctional mannosylated fusion protein in antibody-directed enzyme prodrug therapy. Clin Cancer Res 11:814–825PubMed Sharma SK et al (2005) Sustained tumor regression of human colorectal cancer xenografts using a multifunctional mannosylated fusion protein in antibody-directed enzyme prodrug therapy. Clin Cancer Res 11:814–825PubMed
33.
go back to reference Shih LB et al (1994) Internalization of an intact doxorubicin immunoconjugate. Cancer Immunol Immunother 38:92–98PubMedCrossRef Shih LB et al (1994) Internalization of an intact doxorubicin immunoconjugate. Cancer Immunol Immunother 38:92–98PubMedCrossRef
34.
go back to reference Stein R et al (1999) Carcinoembryonic antigen as a target for radioimmunotherapy of human medullary thyroid carcinoma: antibody processing, targeting, and experimental therapy with 131I and 90Y labeled MAbs. Cancer Biother Radiopharm 14:37–47PubMedCrossRef Stein R et al (1999) Carcinoembryonic antigen as a target for radioimmunotherapy of human medullary thyroid carcinoma: antibody processing, targeting, and experimental therapy with 131I and 90Y labeled MAbs. Cancer Biother Radiopharm 14:37–47PubMedCrossRef
35.
go back to reference Sung C, van Osdol WW (1995) Pharmacokinetic comparison of direct antibody targeting with pretargeting protocols based on streptavidin–biotin binding. J Nucl Med 36:867–876PubMed Sung C, van Osdol WW (1995) Pharmacokinetic comparison of direct antibody targeting with pretargeting protocols based on streptavidin–biotin binding. J Nucl Med 36:867–876PubMed
36.
go back to reference Thurber G, Wittrup KD (2008) Quantitative spatiotemporal analysis of antibody diffusion and endocytic consumption in tumor spheroids. Cancer Res (in press) Thurber G, Wittrup KD (2008) Quantitative spatiotemporal analysis of antibody diffusion and endocytic consumption in tumor spheroids. Cancer Res (in press)
37.
go back to reference Thurber G, Zajik SC, Wittrup KD (2007) Theoretical criteria for antibody saturation of tumors and micrometastases. J Nucl Med 48:995–999PubMedCrossRef Thurber G, Zajik SC, Wittrup KD (2007) Theoretical criteria for antibody saturation of tumors and micrometastases. J Nucl Med 48:995–999PubMedCrossRef
38.
go back to reference Wegener WA et al (2000) Safety and efficacy of arcitumomab imaging in colorectal cancer after repeated administration. J Nucl Med 41:1016–1020PubMed Wegener WA et al (2000) Safety and efficacy of arcitumomab imaging in colorectal cancer after repeated administration. J Nucl Med 41:1016–1020PubMed
39.
go back to reference Yazdi PT, Wenning LA, Murphy RM (1995) Influence of cellular trafficking on protein synthesis inhibition of immunotoxins directed against the transferrin receptor. Cancer Res 55:3763–3771PubMed Yazdi PT, Wenning LA, Murphy RM (1995) Influence of cellular trafficking on protein synthesis inhibition of immunotoxins directed against the transferrin receptor. Cancer Res 55:3763–3771PubMed
40.
go back to reference Zimmermann W et al (1987) Isolation and characterization of cDNA clones encoding the human carcinoembryonic antigen reveal a highly conserved repeating structure. Proc Natl Acad Sci USA 84:2960–2964PubMedCrossRef Zimmermann W et al (1987) Isolation and characterization of cDNA clones encoding the human carcinoembryonic antigen reveal a highly conserved repeating structure. Proc Natl Acad Sci USA 84:2960–2964PubMedCrossRef
Metadata
Title
Kinetics of anti-carcinoembryonic antigen antibody internalization: effects of affinity, bivalency, and stability
Authors
Michael M. Schmidt
Greg M. Thurber
K. Dane Wittrup
Publication date
01-12-2008
Publisher
Springer-Verlag
Published in
Cancer Immunology, Immunotherapy / Issue 12/2008
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-008-0518-1

Other articles of this Issue 12/2008

Cancer Immunology, Immunotherapy 12/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine